logo-loader
RNS
One Health Group PLC

One Health Group PLC - Appointment of Commercial Manager

RNS Number : 1327D
One Health Group PLC
06 May 2026
 

A logo with blue and orange letters AI-generated content may be incorrect.

 

One Health Group plc

("One Health", the "Company" or the "Group")

 

Appointment of Commercial Manager

 

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', announces the appointment of Joe Hopwood as Commercial Manager.

 

Joe joins One Health from NHS South Yorkshire Integrated Care Board where he worked as the transformation and delivery manager. Prior to joining the NHS, Joe was the programme and performance manager at South Yorkshire Police. In his new role at One Health, Joe will be involved in several key areas across the business, including contract negotiations and commercial oversight, and will support the Company in its growth journey and continued execution of its strategy.

 

Joe is skilled in strategic contractual and commercial strategies and stakeholder management with proven national expertise in elective care commissioning legislation, contracts and guidance within the NHS.


Adam Binns, CEO of One Health Group, commented: "This year has been a pivotal period for One Health, and the Board felt now was the right time to further strengthen the management team with this appointment. Joe's NHS experience,
strong commercial awareness, and his analytical capabilities will prove invaluable as we continue to grow and develop. We are delighted to welcome him, and I am confident he will add immense value and insight."


Commenting on his new role, Joe Hopwood said: "I'm thrilled to be joining One Health Group during a period of significant momentum. The team's commitment to improving NHS patient access to high-quality care really stands out, and I'm looking forward to building on this by developing strong partnerships and supporting the Company's continued growth."

 

If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com

 

For more information, please contact:

 

One Health Group plc

Derek Bickerstaff, Chairman

Adam Binns, CEO

 

www.onehealth.co.uk/investors

Via Walbrook PR

Panmure Liberum (Nominated Adviser and Broker)

Emma Earl, Will Goode, Mark Rogers

Rupert Dearden

 

Tel: +44 (0)20 3100 2000

Walbrook PR (Media & Investor Relations)

Alice Woodings / Paul McManus /

Rachel Broad

Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /

                                                                    +44 (0)7747 515 393

 

A blurry image of people AI-generated content may be incorrect.

 

About One Health Group plc (www.onehealth.co.uk)

One Health engages 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2026 provided much needed care to 18,931 new patients, through over 50,000 consultations and over 8,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 140 professionals across 14 independent hospitals and 40 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.

 

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision:

https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSLFUIEMSELI
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read